|
1
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hortobagyi GN: Developments in
chemotherapy of breast cancer. Cancer. 88:3073–3079. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Esteva FJ, Valero V, Pusztai L,
Boehnke-Michaud L, Buzdar AU and Hortobagyi GN: Chemotherapy of
metastatic breast cancer: what to expect in 2001 and beyond.
Oncologist. 6:133–146. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldhirsch A, Wood WC, Coates AS, Gelber
RD, Thurlimann B and Senn HJ: Strategies for subtypes-dealing with
the diversity of breast cancer: highlights of the St. Gallen
International Expert Consensus on the Primary Therapy of Early
Breast Cancer 2011. Ann Oncol. 22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dranoff G: Cytokines in cancer
pathogenesis and cancer therapy. Nat Rev Cancer. 4:11–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ben-Baruch A: Host microenvironment in
breast cancer development: inflammatory cells, cytokines and
chemokines in breast cancer progression: reciprocal
tumor-microenvironment interactions. Breast Cancer Res. 5:31–36.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
May D, Blow MJ, Kaplan T, et al:
Large-scale discovery of enhancers from human heart tissue. Nat
Genet. 44:89–93. 2012. View
Article : Google Scholar
|
|
8
|
Visel A, Blow MJ, Li Z, et al: ChIP-seq
accurately predicts tissue-specific activity of enhancers. Nature.
457:854–858. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marek R, Coelho CM, Sullivan RK, et al:
Paradoxical enhancement of fear extinction memory and synaptic
plasticity by inhibition of the histone acetyltransferase p300. J
Neurosci. 31:7486–7491. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao XS, Cai MY, Chen JW, et al: High
Expression of p300 in Human Breast Cancer Correlates with Tumor
Recurrence and Predicts Adverse Prognosis. Chin J Cancer Res.
23:201–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Xiao X, Zhang Y, et al:
Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling
by melatonin to inhibit proliferation and induce apoptosis in
breast cancer cells. J Pineal Res. 53:77–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Park PJ: ChIP-seq: advantages and
challenges of a maturing technology. Nat Rev Genet. 10:669–680.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Theodorou V, Stark R, Menon S and Carroll
JS: GATA3 acts upstream of FOXA1 in mediating ESR1 binding by
shaping enhancer accessibility. Genome Res. 23:12–22. 2013.
View Article : Google Scholar :
|
|
14
|
Langmead B, Trapnell C, Pop M and Salzberg
SL: Ultrafast and memory-efficient alignment of short DNA sequences
to the human genome. Genome Biol. 10:R252009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Handsaker B, Wysoker A, et al: The
Sequence Alignment/Map format and SAMtools. Bioinformatics.
25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu LJ, Gazin C, Lawson ND, et al:
ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and
ChIP-chip data. BMC Bioinformatics. 11:2372010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng Q and Wang XJ: GOEAST: a web-based
software toolkit for Gene Ontology enrichment analysis. Nucleic
Acids Res. 36:W358–W363. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garcia-Alcalde F, Okonechnikov K,
Carbonell J, et al: Qualimap: evaluating next-generation sequencing
alignment data. Bioinformatics. 28:2678–2679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wilkinson L and Friendly M: The history of
the cluster heat map. Am Stat. 63:2009
|
|
20
|
Vo N and Goodman RH: CREB-binding protein
and p300 in transcriptional regulation. J Biol Chem.
276:13505–13508. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bandyopadhyay D, Okan NA, Bales E,
Nascimento L, Cole PA and Medrano EE: Down-regulation of p300/CBP
histone acetyltransferase activates a senescence checkpoint in
human melanocytes. Cancer Res. 62:6231–6239. 2002.PubMed/NCBI
|
|
22
|
Li M, Luo RZ, Chen JW, et al: High
expression of transcriptional coactivator p300 correlates with
aggressive features and poor prognosis of hepatocellular carcinoma.
J Transl Med. 9:52011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robertson G, Hirst M, Bainbridge M, et al:
Genome-wide profiles of STAT1 DNA association using chromatin
immuno-precipitation and massively parallel sequencing. Nat
Methods. 4:651–657. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Fan H, Shen J, Hoffman RM and
Xing HR: Human breast cancer cell lines co-express neuronal,
epithelial, and melanocytic differentiation markers in vitro and in
vivo. PLoS One. 5:e97122010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sloan EK, Priceman SJ, Cox BF, et al: The
sympathetic nervous system induces a metastatic switch in primary
breast cancer. Cancer Res. 70:7042–7052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dakhova O, Ozen M, Creighton CJ, et al:
Global gene expression analysis of reactive stroma in prostate
cancer. Clin Cancer Res. 15:3979–3989. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Van Swearingen AE, Sanchez CL, Frisbee SM,
et al: Estradiol replacement enhances cocaine-stimulated locomotion
in female C57BL/6 mice through estrogen receptor alpha.
Neuropharmacology. 72:236–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grimstad IA: Direct evidence that cancer
cell locomotion contributes importantly to invasion. Exp Cell Res.
173:515–523. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nitta H, Wada Y, Kawano Y, et al:
Enhancement of human cancer cell motility and invasiveness by
anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Clin Cancer Res. 19:2004–2013. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hein S, Muller V, Kohler N, et al:
Biologic role of activated leukocyte cell adhesion molecule
overexpression in breast cancer cell lines and clinical tumor
tissue. Breast Cancer Res Treat. 129:347–360. 2011. View Article : Google Scholar
|
|
31
|
Ariazi EA, Clark GM and Mertz JE:
Estrogen-related receptor alpha and estrogen-related receptor gamma
associate with unfa-vorable and favorable biomarkers, respectively,
in human breast cancer. Cancer Res. 62:6510–6518. 2002.PubMed/NCBI
|
|
32
|
Riggins RB, Mazzotta MM, Maniya OZ and
Clarke R: Orphan nuclear receptors in breast cancer pathogenesis
and therapeutic response. Endocr Relat Cancer. 17:R213–R231. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stein RA: Memory transience, medical
history and insurance. Int J Clin Pract. 62:850–851. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stein RA, Gaillard S and McDonnell DP:
Estrogen-related receptor alpha induces the expression of vascular
endothelial growth factor in breast cancer cells. J Steroid Biochem
Mol Biol. 114:106–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salzman J, Marinelli RJ, Wang PL, et al:
ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian
carcinoma. PLoS Biol. 9:e10011562011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lupien M, Eeckhoute J, Meyer CA, et al:
FoxA1 translates epigenetic signatures into enhancer-driven
lineage-specific transcription. Cell. 132:958–970. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Eeckhoute J, Keeton EK, Lupien M, Krum SA,
Carroll JS and Brown M: Positive cross-regulatory loop ties GATA-3
to estrogen receptor alpha expression in breast cancer. Cancer Res.
67:6477–6483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mullan PB, Quinn JE and Harkin DP: The
role of BRCA1 in transcriptional regulation and cell cycle control.
Oncogene. 25:5854–5863. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gorski JJ, Kennedy RD, Hosey AM and Harkin
DP: The complex relationship between BRCA1 and ERalpha in
hereditary breast cancer. Clin Cancer Res. 15:1514–1518. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jeffy BD, Hockings JK, Kemp MQ, et al: An
estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter
at an AP-1 site that binds Jun/Fos transcription factors:
repressive effects of p53 on BRCA-1 transcription. Neoplasia.
7:873–882. 2005. View Article : Google Scholar : PubMed/NCBI
|
